Search
for
Sort by
Research 30 of 410
- Chemotherapy‐induced alopecia: an exploratory questionnaire‐based study from Israel comparing knowledge, attitudes, and management practices among dermatologists and oncologists
- A Radiation Oncologist Writes
- Alterações dermatológicas em pacientes oncológicos – adultos e crianças
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras
- Pain in pancreatic cancer: A medical oncologist's view
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- Management of Dermatologic Toxicities
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Aesthetic medicine treatments for oncology patients — a narrative literature review
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
- Clinical perspective on management of key adverse events with sacituzumab govitecan
- Insurers Give Short Shrift to ASCO Pathways Recommendation
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Excessive hair growth around local β‐interferon injection sites for malignant melanoma
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Cutaneous toxicities of new treatments for melanoma
- Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- Identifying emotional variations in Spanish oncology patients during treatment decision consultations: a qualitative study
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials